Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts. Pronsati N, Liu G, Bauer TM, Felip E, et al. Lung Cancer 2025;206:108662.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pronsati N, Liu G, Bauer TM, Felip E, et al. Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts. Lung Cancer 2025;206:108662.
PMID: 40714367